CVE-2024-13502

A command injection in the NTC2218, NTC2250, NTC2299 modems' web interfaces allows to exeucte arbitrary shell commands.

Description

Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') vulnerability in Newtec/iDirect NTC2218, NTC2250, NTC2299 on Linux, PowerPC, ARM allows Local Code Inclusion.This issue affects NTC2218, NTC2250, NTC2299: from 1.0.1.1 through 2.2.6.19. The `commit_multicast` page used to configure multicasts in the modem's web administration interface uses improperly parses incoming data from the request before passing it to an `eval` statement in a bash script. This allows attackers to inject arbitrary shell commands.

Category

9.3
CVSS
Severity: Critical
CVSS 4.0 •
EPSS 4.85% Top 15%
Affected: Newtec/iDirect NTC2218, NTC2250, NTC2299
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-13502?
CVE-2024-13502 has been scored as a critical severity vulnerability.
How to fix CVE-2024-13502?
To fix CVE-2024-13502, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-13502 being actively exploited in the wild?
It is possible that CVE-2024-13502 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~5% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-13502?
CVE-2024-13502 affects Newtec/iDirect NTC2218, NTC2250, NTC2299.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.